XENON PHARMACEUTICALS INC. (XENE) Net income 2016–2025
XENON PHARMACEUTICALS INC. (XENE) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$345.9MFY2025 · since FY2016: -$23.0M → -$345.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$345.9M | -47.6% |
| FY2024 | -$234.3M | -28.5% |
| FY2023 | -$182.4M | -45.5% |
| FY2022 | -$125.4M | -58.9% |
| FY2021 | -$78.9M | -173.5% |
| FY2020 | -$28.8M | +30.7% |
| FY2019 | -$41.6M | -20.6% |
| FY2018 | -$34.5M | -12.4% |
| FY2017 | -$30.7M | -33.5% |
| FY2016 | -$23.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice